Galmed Pharmaceuticals Ltd. (GLMD)

0.613 0.00 (0.00%) USD  |  NASDAQ  |  Feb 13, 16:00
0.6044 -0.01 (-1.40%) Pre-Market: 20:00
More

Galmed Pharmaceuticals Total Expenses (Quarterly)

Total Expenses (Quarterly) Chart

View Total Expenses (Quarterly) for GLMD.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Expenses (Quarterly) Range, Past 5 Years

View Total Expenses (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (Quarterly) Benchmarks

View Total Expenses (Quarterly) Benchmarks
Start Trial
Compugen Ltd. Upgrade
Pluri, Inc. Upgrade
BioLineRx Ltd. Upgrade
XTL Biopharmaceuticals Ltd. Upgrade
Can-Fite BioPharma Ltd. --

Total Expenses (Quarterly) Related Metrics

Net Income (Quarterly) Upgrade
EPS Diluted (Quarterly) Upgrade
Enterprise Value Upgrade
Earnings Yield Upgrade
Normalized Earnings Yield Upgrade